{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T10:56:40Z","timestamp":1792407400858,"version":"4.4.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T00:00:00Z","timestamp":1643760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T00:00:00Z","timestamp":1643760000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s12026-022-09268-x","type":"journal-article","created":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T12:02:52Z","timestamp":1643803372000},"page":"269-275","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":74,"title":["PI3K\/Akt\/mTOR pathway: a potential target for anti-SARS-CoV-2 therapy"],"prefix":"10.1007","volume":"70","author":[{"given":"Soheila","family":"Fattahi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Khalifehzadeh-Esfahani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Mohammad-Rezaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar","family":"Mafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3272-448X","authenticated-orcid":false,"given":"Morteza","family":"Jafarinia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,2]]},"reference":[{"key":"9268_CR1","doi-asserted-by":"publisher","first-page":"591830","DOI":"10.3389\/fmed.2021.591830","volume":"8","author":"F Yang","year":"2021","unstructured":"Yang F, Chen R, Li WY, Zhu HY, Chen XX, Hou ZF, et al. D-Limonene is a potential monoterpene to inhibit PI3K\/Akt\/IKK-\u03b1\/NF-\u03baB p65 signaling pathway in coronavirus disease 2019 pulmonary fibrosis. Front Med. 2021;8:591830. https:\/\/doi.org\/10.3389\/fmed.2021.591830.","journal-title":"Front Med"},{"issue":"9","key":"9268_CR2","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1002\/jmv.26009","volume":"92","author":"Y Zheng","year":"2020","unstructured":"Zheng Y, Li R, Liu S. Immunoregulation with mTOR inhibitors to prevent COVID-19 severity: a novel intervention strategy beyond vaccines and specific antiviral medicines. J Med Virol. 2020;92(9):1495\u2013500. https:\/\/doi.org\/10.1002\/jmv.26009.","journal-title":"J Med Virol"},{"issue":"1","key":"9268_CR3","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1038\/s41467-021-22166-4","volume":"12","author":"PJ Mullen","year":"2021","unstructured":"Mullen PJ, Garcia G Jr, Purkayastha A, Matulionis N, Schmid EW, Momcilovic M, et al. SARS-CoV-2 infection rewires host cell metabolism and is potentially susceptible to mTORC1 inhibition. Nat Commun. 2021;12(1):1876. https:\/\/doi.org\/10.1038\/s41467-021-22166-4.","journal-title":"Nat Commun"},{"issue":"1","key":"9268_CR4","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1080\/22221751.2020.1799723","volume":"9","author":"S Appelberg","year":"2020","unstructured":"Appelberg S, Gupta S, Svensson Akusj\u00e4rvi S, Ambikan AT, Mikaeloff F, Saccon E, et al. Dysregulation in Akt\/mTOR\/HIF-1 signaling identified by proteo-transcriptomics of SARS-CoV-2 infected cells. Emerging microbes & infections. 2020;9(1):1748\u201360. https:\/\/doi.org\/10.1080\/22221751.2020.1799723.","journal-title":"Emerging microbes & infections"},{"key":"9268_CR5","doi-asserted-by":"publisher","first-page":"e929279","DOI":"10.12659\/aot.929279","volume":"26","author":"NB Hasbal","year":"2021","unstructured":"Hasbal NB, Turgut D, Gok Oguz E, Ulu S, Gungor O. Effect of calcineurin inhibitors and mammalian target of rapamycin inhibitors on the course of COVID-19 in kidney transplant recipients. Ann Transplant. 2021;26:e929279. https:\/\/doi.org\/10.12659\/aot.929279.","journal-title":"Ann Transplant"},{"key":"9268_CR6","doi-asserted-by":"publisher","unstructured":"Borchers C, Thyagarajan A, Rapp CM, Travers JB, Sahu RP. Evaluation of SARS-CoV-2 spike S1 protein response on PI3K-mediated IL-8 release. Med Sci. 2021;9(2):30.\u00a0https:\/\/doi.org\/10.3390\/medsci9020030.","DOI":"10.3390\/medsci9020030"},{"issue":"2","key":"9268_CR7","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","volume":"149","author":"M Laplante","year":"2012","unstructured":"Laplante M, Sabatini DM. mTOR signaling in growth control and disease. Cell. 2012;149(2):274\u201393. https:\/\/doi.org\/10.1016\/j.cell.2012.03.017.","journal-title":"Cell"},{"key":"9268_CR8","doi-asserted-by":"publisher","unstructured":"Patocka J, Kuca K, Oleksak P, Nepovimova E, Valis M, Novotny M, et al. Rapamycin: drug repurposing in SARS-CoV-2 infection. Pharmaceuticals (Basel). 2021;14(3):217.\u00a0https:\/\/doi.org\/10.3390\/ph14030217.","DOI":"10.3390\/ph14030217"},{"key":"9268_CR9","doi-asserted-by":"publisher","first-page":"100765","DOI":"10.1016\/j.genrep.2020.100765","volume":"20","author":"MJ Ramaiah","year":"2020","unstructured":"Ramaiah MJ. mTOR inhibition and p53 activation, microRNAs: the possible therapy against pandemic COVID-19. Gene reports. 2020;20:100765. https:\/\/doi.org\/10.1016\/j.genrep.2020.100765.","journal-title":"Gene reports"},{"key":"9268_CR10","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.3389\/fimmu.2020.02094","volume":"11","author":"G Palma","year":"2020","unstructured":"Palma G, Pasqua T, Silvestri G, Rocca C, Gualtieri P, Barbieri A, et al. PI3K\u03b4 Inhibition as a potential therapeutic target in COVID-19. Front Immunol. 2020;11:2094. https:\/\/doi.org\/10.3389\/fimmu.2020.02094.","journal-title":"Front Immunol"},{"key":"9268_CR11","doi-asserted-by":"publisher","first-page":"108464","DOI":"10.1016\/j.clim.2020.108464","volume":"216","author":"L Omarjee","year":"2020","unstructured":"Omarjee L, Janin A, Perrot F, Laviolle B, Meilhac O, Mahe G. Targeting T-cell senescence and cytokine storm with rapamycin to prevent severe progression in COVID-19. Clinical immunology (Orlando, Fla). 2020;216:108464. https:\/\/doi.org\/10.1016\/j.clim.2020.108464.","journal-title":"Clinical immunology (Orlando, Fla)"},{"issue":"4","key":"9268_CR12","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.celrep.2012.02.007","volume":"1","author":"Y Kurebayashi","year":"2012","unstructured":"Kurebayashi Y, Nagai S, Ikejiri A, Ohtani M, Ichiyama K, Baba Y, et al. PI3K-Akt-mTORC1-S6K1\/2 axis controls Th17 differentiation by regulating Gfi1 expression and nuclear translocation of ROR\u03b3. Cell Rep. 2012;1(4):360\u201373. https:\/\/doi.org\/10.1016\/j.celrep.2012.02.007.","journal-title":"Cell Rep"},{"key":"9268_CR13","doi-asserted-by":"publisher","unstructured":"de Souza AP, de Freitas DN, Antuntes Fernandes KE, D\u2019Avila da Cunha M, Antunes Fernandes JL, Benetti Gassen R et al. Respiratory syncytial virus induces phosphorylation of mTOR at ser2448 in CD8 T cells from nasal washes of infected infants. Clinical and experimental immunology. 2016;183(2):248\u201357. https:\/\/doi.org\/10.1111\/cei.12720.","DOI":"10.1111\/cei.12720"},{"issue":"2","key":"9268_CR14","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1128\/aac.03659-14","volume":"59","author":"J Kindrachuk","year":"2015","unstructured":"Kindrachuk J, Ork B, Hart BJ, Mazur S, Holbrook MR, Frieman MB, et al. Antiviral potential of ERK\/MAPK and PI3K\/AKT\/mTOR signaling modulation for Middle East respiratory syndrome coronavirus infection as identified by temporal kinome analysis. Antimicrob Agents Chemother. 2015;59(2):1088\u201399. https:\/\/doi.org\/10.1128\/aac.03659-14.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"9268_CR15","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann M, Kleine-Weber H, Schroeder S, Kr\u00fcger N, Herrler T, Erichsen S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271-80.e8. https:\/\/doi.org\/10.1016\/j.cell.2020.02.052.","journal-title":"Cell"},{"key":"9268_CR16","doi-asserted-by":"publisher","unstructured":"Garcia Jr G, Sharma A, Ramaiah A, Sen C, Kohn DB, Gomperts BN, et al. Antiviral drug screen of kinase inhibitors identifies cellular signaling pathways critical for SARS-CoV-2 replication. 2020.\u00a0Available at SSRN: https:\/\/ssrn.com\/abstract=3682004 or https:\/\/doi.org\/10.2139\/ssrn.3682004.","DOI":"10.2139\/ssrn.3682004"},{"issue":"1","key":"9268_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-021-22166-4","volume":"12","author":"PJ Mullen","year":"2021","unstructured":"Mullen PJ, Garcia G, Purkayastha A, Matulionis N, Schmid EW, Momcilovic M, et al. SARS-CoV-2 infection rewires host cell metabolism and is potentially susceptible to mTORC1 inhibition. Nat Commun. 2021;12(1):1\u201310.","journal-title":"Nat Commun"},{"key":"9268_CR18","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3389\/fonc.2014.00064","volume":"4","author":"C Porta","year":"2014","unstructured":"Porta C, Paglino C, Mosca A. Targeting PI3K\/Akt\/mTOR signaling in cancer. Front Oncol. 2014;4:64.","journal-title":"Front Oncol"},{"issue":"8","key":"9268_CR19","doi-asserted-by":"publisher","first-page":"12353","DOI":"10.1002\/jcp.28042","volume":"234","author":"D Rostamzadeh","year":"2019","unstructured":"Rostamzadeh D, Yousefi M, Haghshenas MR, Ahmadi M, Dolati S, Babaloo Z. mTOR Signaling pathway as a master regulator of memory CD8+ T-cells, Th17, and NK cells development and their functional properties. J Cell Physiol. 2019;234(8):12353\u201368.","journal-title":"J Cell Physiol"},{"issue":"20","key":"9268_CR20","doi-asserted-by":"publisher","first-page":"3589","DOI":"10.1242\/jcs.051011","volume":"122","author":"M Laplante","year":"2009","unstructured":"Laplante M, Sabatini DM. mTOR signaling at a glance. J Cell Sci. 2009;122(20):3589\u201394.","journal-title":"J Cell Sci"},{"issue":"5","key":"9268_CR21","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3851\/imp2080","volume":"22","author":"JL Murray","year":"2012","unstructured":"Murray JL, McDonald NJ, Sheng J, Shaw MW, Hodge TW, Rubin DH, et al. Inhibition of influenza A virus replication by antagonism of a PI3K-AKT-mTOR pathway member identified by gene-trap insertional mutagenesis. Antiviral Chem Chemother. 2012;22(5):205\u201315. https:\/\/doi.org\/10.3851\/imp2080.","journal-title":"Antiviral Chem Chemother"},{"issue":"2","key":"9268_CR22","doi-asserted-by":"publisher","first-page":"175","DOI":"10.4161\/auto.22791","volume":"9","author":"H Huang","year":"2013","unstructured":"Huang H, Kang R, Wang J, Luo G, Yang W, Zhao Z. Hepatitis C virus inhibits AKT-tuberous sclerosis complex (TSC), the mechanistic target of rapamycin (MTOR) pathway, through endoplasmic reticulum stress to induce autophagy. Autophagy. 2013;9(2):175\u201395.","journal-title":"Autophagy"},{"issue":"11","key":"9268_CR23","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.jgg.2011.10.002","volume":"38","author":"J Ma","year":"2011","unstructured":"Ma J, Sun Q, Mi R, Zhang H. Avian influenza A virus H5N1 causes autophagy-mediated cell death through suppression of mTOR signaling. J Genet Genomics. 2011;38(11):533\u20137.","journal-title":"J Genet Genomics"},{"issue":"4","key":"9268_CR24","first-page":"e01984","volume":"93","author":"R Wang","year":"2019","unstructured":"Wang R, Zhu Y, Zhao J, Ren C, Li P, Chen H, et al. Autophagy promotes replication of influenza A virus in vitro. J Virol. 2019;93(4):e01984-e2018.","journal-title":"J Virol"},{"issue":"5","key":"9268_CR25","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.stem.2016.07.019","volume":"19","author":"Q Liang","year":"2016","unstructured":"Liang Q, Luo Z, Zeng J, Chen W, Foo S-S, Lee S-A, et al. Zika virus NS4A and NS4B proteins deregulate Akt-mTOR signaling in human fetal neural stem cells to inhibit neurogenesis and induce autophagy. Cell Stem Cell. 2016;19(5):663\u201371.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"9268_CR26","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s10549-010-0763-9","volume":"123","author":"M Zakikhani","year":"2010","unstructured":"Zakikhani M, Blouin M-J, Piura E, Pollak MN. Metformin and rapamycin have distinct effects on the AKT pathway and proliferation in breast cancer cells. Breast Cancer Res Treat. 2010;123(1):271\u20139.","journal-title":"Breast Cancer Res Treat"},{"key":"9268_CR27","doi-asserted-by":"publisher","unstructured":"Kamyshnyi O, Matskevych V, Lenchuk T, Strilbytska O, Storey K, Lushchak O. Metformin to decrease COVID-19 severity and mortality: molecular mechanisms and therapeutic potential. Biomed Pharmacother.\u00a02021;144:112230. https:\/\/doi.org\/10.1016\/j.biopha.2021.112230.","DOI":"10.1016\/j.biopha.2021.112230"},{"issue":"7448","key":"9268_CR28","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nature12122","volume":"497","author":"H Yang","year":"2013","unstructured":"Yang H, Rudge DG, Koos JD, Vaidialingam B, Yang HJ, Pavletich NP. mTOR kinase structure, mechanism and regulation. Nature. 2013;497(7448):217\u201323. https:\/\/doi.org\/10.1038\/nature12122.","journal-title":"Nature"},{"issue":"11","key":"9268_CR29","doi-asserted-by":"publisher","first-page":"e1007428","DOI":"10.1371\/journal.ppat.1007428","volume":"14","author":"X Jia","year":"2018","unstructured":"Jia X, Liu B, Bao L, Lv Q, Li F, Li H, et al. Delayed oseltamivir plus sirolimus treatment attenuates H1N1 virus-induced severe lung injury correlated with repressed NLRP3 inflammasome activation and inflammatory cell infiltration. PLoS Pathog. 2018;14(11):e1007428. https:\/\/doi.org\/10.1371\/journal.ppat.1007428.","journal-title":"PLoS Pathog"},{"key":"9268_CR30","doi-asserted-by":"publisher","unstructured":"Sharma S, Ray A, Sadasivam B. Metformin in COVID-19: a possible role beyond diabetes.\u00a0Diabetes Res Clin Pract. 2020;164:108183. https:\/\/doi.org\/10.1016\/j.diabres.2020.108183.","DOI":"10.1016\/j.diabres.2020.108183"},{"issue":"2","key":"9268_CR31","first-page":"1029","volume":"2","author":"BC Melnik","year":"2014","unstructured":"Melnik BC, Schmitz G. Metformin: an inhibitor of mTORC1 signaling. J Endocrinol Diabetes Obes. 2014;2(2):1029.","journal-title":"J Endocrinol Diabetes Obes"},{"issue":"6","key":"9268_CR32","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1099\/jgv.0.000802","volume":"98","author":"Q Liu","year":"2017","unstructured":"Liu Q, Miller LC, Blecha F, Sang Y. Reduction of infection by inhibiting mTOR pathway is associated with reversed repression of type I interferon by porcine reproductive and respiratory syndrome virus. J Gen Virol. 2017;98(6):1316\u201328. https:\/\/doi.org\/10.1099\/jgv.0.000802.","journal-title":"J Gen Virol"},{"issue":"8","key":"9268_CR33","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1080\/15384047.2015.1056409","volume":"16","author":"L Wang","year":"2015","unstructured":"Wang L, Tang C, Cao H, Li K, Pang X, Zhong L, et al. Activation of IL-8 via PI3K\/Akt-dependent pathway is involved in leptin-mediated epithelial-mesenchymal transition in human breast cancer cells. Cancer Biol Ther. 2015;16(8):1220\u201330. https:\/\/doi.org\/10.1080\/15384047.2015.1056409.","journal-title":"Cancer Biol Ther"},{"issue":"1\u20132","key":"9268_CR34","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.bbadis.2005.04.004","volume":"1741","author":"T Mizutani","year":"2005","unstructured":"Mizutani T, Fukushi S, Saijo M, Kurane I, Morikawa S. JNK and PI3k\/Akt signaling pathways are required for establishing persistent SARS-CoV infection in Vero E6 cells. Biochem Biophys Acta. 2005;1741(1\u20132):4\u201310. https:\/\/doi.org\/10.1016\/j.bbadis.2005.04.004.","journal-title":"Biochem Biophys Acta"},{"key":"9268_CR35","doi-asserted-by":"publisher","first-page":"856","DOI":"10.3389\/fphar.2020.00856","volume":"11","author":"G Terrazzano","year":"2020","unstructured":"Terrazzano G, Rubino V, Palatucci AT, Giovazzino A, Carriero F, Ruggiero G. An open question: is it rational to inhibit the mTor-dependent pathway as COVID-19 therapy? Front Pharmacol. 2020;11:856. https:\/\/doi.org\/10.3389\/fphar.2020.00856.","journal-title":"Front Pharmacol"},{"issue":"6","key":"9268_CR36","doi-asserted-by":"publisher","first-page":"e0129658","DOI":"10.1371\/journal.pone.0129658","volume":"10","author":"O Traitanon","year":"2015","unstructured":"Traitanon O, Mathew JM, La Monica G, Xu L, Mas V, Gallon L. Differential Effects of tacrolimus versus sirolimus on the proliferation, activation and differentiation of human B cells. PLoS ONE. 2015;10(6):e0129658. https:\/\/doi.org\/10.1371\/journal.pone.0129658.","journal-title":"PLoS ONE"},{"issue":"7","key":"9268_CR37","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1158\/1535-7163.mct-09-1012","volume":"9","author":"H Hirai","year":"2010","unstructured":"Hirai H, Sootome H, Nakatsuru Y, Miyama K, Taguchi S, Tsujioka K, et al. MK-2206, an allosteric Akt inhibitor, enhances antitumor efficacy by standard chemotherapeutic agents or molecular targeted drugs in vitro and in vivo. Mol Cancer Ther. 2010;9(7):1956\u201367. https:\/\/doi.org\/10.1158\/1535-7163.mct-09-1012.","journal-title":"Mol Cancer Ther"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-022-09268-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12026-022-09268-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-022-09268-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T00:15:07Z","timestamp":1655252107000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12026-022-09268-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,2]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["9268"],"URL":"https:\/\/doi.org\/10.1007\/s12026-022-09268-x","relation":{},"ISSN":["0257-277X","1559-0755"],"issn-type":[{"value":"0257-277X","type":"print"},{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,2]]},"assertion":[{"value":"9 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}